{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:09:48Z","timestamp":1788174588922,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100019714","name":"Foundation Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.modpat.2024.100615","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T17:30:01Z","timestamp":1727112601000},"page":"100615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms\/Syndromes\u2014Recommendations From the International Consortium for Myelodysplastic Neoplasms\/Syndromes (MDS [icMDS])"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-1958","authenticated-orcid":false,"given":"Fnu","family":"Aakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savanah D.","family":"Gisriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer M.","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Philipp","family":"Bewersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma M.","family":"Borate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Boultwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Buckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty E.","family":"Carraway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Churpek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naval G.","family":"Daver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"DeZern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Efficace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garcia-Manero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Halene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Hourigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Kon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami S.","family":"Komrokji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Kutchroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"List","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Majeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Nazha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Nimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatoyosi","family":"Odenike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Padron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo G.","family":"Della Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail J.","family":"Roboz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Sallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Savona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Starczynowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoer","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-3202","authenticated-orcid":false,"given":"Sanam","family":"Loghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2024.100615_bib1","series-title":"WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"7","key":"10.1016\/j.modpat.2024.100615_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.modpat.2024.100615_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.modpat.2024.100615_bib4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.modpat.2024.100615_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"10","key":"10.1016\/j.modpat.2024.100615_bib6","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/s41375-019-0457-1","article-title":"Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome","volume":"33","author":"Bono","year":"2019","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.modpat.2024.100615_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.modpat.2024.100615_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00277-008-0483-y","article-title":"Cytogenetic features in myelodysplastic syndromes","volume":"87","author":"Haase","year":"2008","journal-title":"Ann Hematol"},{"issue":"17","key":"10.1016\/j.modpat.2024.100615_bib9","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood-2016-12-754796","article-title":"Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation","volume":"129","author":"Yoshizato","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.modpat.2024.100615_bib10","doi-asserted-by":"crossref","first-page":"E420","DOI":"10.1002\/ajh.26325","article-title":"Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations","volume":"96","author":"Wang","year":"2021","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng.1031","article-title":"Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes","volume":"44","author":"Graubert","year":"2011","journal-title":"Nat Genet"},{"issue":"22","key":"10.1016\/j.modpat.2024.100615_bib12","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in TET2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.modpat.2024.100615_bib13","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1038\/s41375-019-0617-3","article-title":"The functional mechanisms of mutations in myelodysplastic syndrome","volume":"33","author":"Nagata","year":"2019","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.modpat.2024.100615_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.modpat.2024.100615_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2024.100615_bib16","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","article-title":"High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.modpat.2024.100615_bib17","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood.2021014309","article-title":"Guiding the global evolution of cytogenetic testing for hematologic malignancies","volume":"139","author":"Akkari","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.modpat.2024.100615_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/leu.2014.191","article-title":"Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International\/European LeukemiaNet Working Group for Flow Cytometry in MDS","volume":"28","author":"Porwit","year":"2014","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.modpat.2024.100615_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cyto.b.21224","article-title":"Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: a study on 804 patients","volume":"88","author":"Kern","year":"2015","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"10.1016\/j.modpat.2024.100615_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cll.2023.04.007","article-title":"Clinical flow cytometry analysis in the setting of chronic myeloid neoplasms and clonal hematopoiesis","volume":"43","author":"El Hussein","year":"2023","journal-title":"Clin Lab Med"},{"issue":"8","key":"10.1016\/j.modpat.2024.100615_bib21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.modpat.2024.100615_bib22","first-page":"7449","article-title":"Simplified flow cytometry scoring for diagnosis and prognosis of myelodysplastic symptom","volume":"12","author":"Guo","year":"2020","journal-title":"Am J Transl Res"},{"issue":"7","key":"10.1016\/j.modpat.2024.100615_bib23","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.modpat.2024.100615_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fonc.2017.00270","article-title":"The use of flow cytometry in myelodysplastic syndromes: a review","volume":"7","author":"Bento","year":"2017","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100615_bib25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2009.008532","article-title":"Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study","volume":"94","author":"Ogata","year":"2009","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cyto.b.22105","article-title":"Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group","volume":"104","author":"Kern","year":"2023","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cyto.b.22108","article-title":"Multiparameter flow cytometry in the evaluation of myelodysplasia: analytical issues: recommendations from the European LeukemiaNet\/International Myelodysplastic Syndrome Flow Cytometry Working Group","volume":"104","author":"Porwit","year":"2023","journal-title":"Cytometry B Clin Cytom"},{"issue":"8","key":"10.1016\/j.modpat.2024.100615_bib28","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/bloodadvances.2020003976","article-title":"Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.modpat.2024.100615_bib29","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid"},{"issue":"15","key":"10.1016\/j.modpat.2024.100615_bib30","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib31","first-page":"82","article-title":"Role of luspatercept in the management of lower-risk myelodysplastic syndromes","volume":"14","author":"Tinsley-Vance","year":"2023","journal-title":"J\u00a0Adv Pract Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100615_bib32","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","article-title":"Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes","volume":"26","author":"Bernard","year":"2020","journal-title":"Nat Med"},{"issue":"15","key":"10.1016\/j.modpat.2024.100615_bib33","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1182\/blood.2021014472","article-title":"Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"139","author":"Grob","year":"2022","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.modpat.2024.100615_bib34","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.3390\/cancers13215392","article-title":"TP53 in myelodysplastic syndromes","volume":"13","author":"Jiang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood.2021013983","article-title":"TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia","volume":"140","author":"Tashakori","year":"2022","journal-title":"Blood"},{"issue":"7595","key":"10.1016\/j.modpat.2024.100615_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature17157","article-title":"Deletions linked to TP53 loss drive cancer through p53-independent mechanisms","volume":"531","author":"Liu","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.modpat.2024.100615_bib37","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41375-018-0351-2","article-title":"TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups","volume":"33","author":"Haase","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.modpat.2024.100615_bib38","first-page":"338","article-title":"p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia","volume":"145","author":"Kitagawa","year":"1994","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100615_bib39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.modpat.2024.100615_bib40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1182\/blood-2022-170158","article-title":"A\u00a0product of \u201cClash of Titans\u201d or true reflection of disease biology? Validation of 2022 WHO and ICC classifications in a large dataset of patients with myelodysplastic syndrome","volume":"140","author":"Ball","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.modpat.2024.100615_bib41","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.3324\/haematol.2015.130112","article-title":"Genomic patterns associated with hypoplastic compared to hyperplastic myelodysplastic syndromes","volume":"100","author":"Nazha","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2024.100615_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bjh.19241","article-title":"Revisiting the first reported case of aplastic anaemia","volume":"204","author":"Steensma","year":"2024","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100615_bib43","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood-2018-10-844670","article-title":"MDS overlap disorders and diagnostic boundaries","volume":"133","author":"Tanaka","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100615_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101276","article-title":"Immunologic effects on the haematopoietic stem cell in marrow failure","volume":"34","author":"Patel","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100615_bib45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/modpathol.2013.187","article-title":"Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems","volume":"27","author":"Fu","year":"2014","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bjh.13529","article-title":"TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis","volume":"171","author":"Loghavi","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1365-2141.1996.d01-1786.x","article-title":"The bone marrow aspirate of healthy subjects","volume":"94","author":"Bain","year":"1996","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100615_bib48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11899-012-0140-3","article-title":"Dysplasia has a differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors","volume":"7","author":"Steensma","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"issue":"2","key":"10.1016\/j.modpat.2024.100615_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.2830420217","article-title":"Zinc abuse and sideroblastic anemia","volume":"42","author":"Ramadurai","year":"1993","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100615_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jclinpath-2014-202837","article-title":"The risk of copper deficiency in patients prescribed zinc supplements","volume":"68","author":"Duncan","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100615_bib51","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2002-01-0256","article-title":"Copper deficiency masquerading as myelodysplastic syndrome","volume":"100","author":"Gregg","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0037-1963(00)90027-1","article-title":"Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?","volume":"37","author":"Barrett","year":"2000","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100615_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.blre.2010.03.002","article-title":"Pathophysiology and management of inherited bone marrow failure syndromes","volume":"24","author":"Shimamura","year":"2010","journal-title":"Blood Rev"},{"issue":"10","key":"10.1016\/j.modpat.2024.100615_bib54","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3324\/haematol.2017.167726","article-title":"Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation","volume":"102","author":"Kanagal-Shamanna","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.modpat.2024.100615_bib55","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"14","key":"10.1016\/j.modpat.2024.100615_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121086","article-title":"Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes","volume":"3","author":"Wong","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.modpat.2024.100615_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","article-title":"Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7","volume":"24","author":"Nagamachi","year":"2013","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.modpat.2024.100615_bib58","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2018-10-844662","article-title":"Genetic predisposition to MDS: clinical features and clonal evolution","volume":"133","author":"Kennedy","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2024.100615_bib59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ajcp\/aqad075","article-title":"How I diagnose myeloid neoplasms with germline predisposition","volume":"160","author":"Patel","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100615_bib60","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ajcp\/aqz067","article-title":"Germline predisposition to hematolymphoid neoplasia","volume":"152","author":"Weinberg","year":"2019","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100615_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","article-title":"Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study","volume":"55","author":"Mekinian","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.modpat.2024.100615_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40164-021-00217-2","article-title":"VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder","volume":"10","author":"Huang","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100615_bib63","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/diagnostics12071590","article-title":"VEXAS syndrome: a novelty in MDS landscape","volume":"12","author":"Templ\u00e9","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.modpat.2024.100615_bib64","article-title":"New scenarios in vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: evolution from myelodysplastic syndrome to acute myeloid leukemia","volume":"71","author":"Battipaglia","year":"2023","journal-title":"Curr Res Transl Med"},{"issue":"12","key":"10.1016\/j.modpat.2024.100615_bib65","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.modpat.2024.100615_bib66","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.modpat.2024.100615_bib67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.modpat.2024.100615_bib68","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1038\/leu.2017.266","article-title":"Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes","volume":"31","author":"Nazha","year":"2017","journal-title":"Leukemia"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:06:17Z","timestamp":1764551177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224001959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0893395224001959"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100615","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms\/Syndromes\u2014Recommendations From the International Consortium for Myelodysplastic Neoplasms\/Syndromes (MDS [icMDS])","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100615"}}